Impact of AmpC derepression on fitness and virulence: the mechanism or the pathway?

mBio

Volumn 7, Issue 5, 2016, Pages

  Pérez Gallego, Marcelo ^a   Torrens, Gabriel ^a   Castillo Vera, Jane ^a   Moya, Bartolomé ^a   Zamorano, Laura ^a   Cabot, Gabriel ^a   Hultenby, Kjell ^b   Albertí, Sebastián ^c   Mellroth, Peter ^d   Henriques Normark, Birgitta ^b,d   Normark, Staffan ^d   Oliver, Antonio ^a   Juan, Carlos ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; AMIDASE AMPD; AMIDASE AMPDH2; AMIDASE AMPDH3; BACTERIAL ENZYME; BETA LACTAM; BETA LACTAMASE AMPC; LACTATE DEHYDROGENASE; PHOSPHOLIPASE C; PROTEASE LASA; UNCLASSIFIED DRUG; AMPC BETA-LACTAMASES; AMPD PROTEIN, BACTERIA; AMPG PROTEIN, BACTERIA; BACTERIAL PROTEIN; BETA LACTAMASE; CARRIER PROTEIN; N ACETYLMURAMOYLALANINE AMIDASE; PEPTIDOGLYCAN;

AMPC GENE; AMPD GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL FITNESS; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL MOTILITY; BACTERIAL PATHOGENESIS; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL VIRULENCE; CELL WALL RECYCLING; CONTROLLED STUDY; CYTOTOXICITY; ENZYME RELEASE; ENZYME SYNTHESIS; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE OVEREXPRESSION; GROWTH RATE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TRANSCRIPTOMICS; TYPE III SECRETION SYSTEM; BIOSYNTHESIS; CELL WALL; ENZYMOLOGY; GENE DELETION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; VIRULENCE;

BACTERIAL PROTEINS; BETA-LACTAMASES; CELL WALL; GENE DELETION; MEMBRANE TRANSPORT PROTEINS; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDOGLYCAN; PSEUDOMONAS AERUGINOSA; VIRULENCE;

EID: 84995387877     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01783-16     Document Type: Article

References (53)

1. Livermore DM. 2009. Has the era of untreatable infections arrived? J Antimicrob Chemother 64(Suppl 1):i29–i36. http://dx.doi.org/10.1093/jac/dkp255.
2. Melnyk AH, Wong A, Kassen R. 2015. The fitness costs of antibiotic resistance mutations. Evol Appl 8:273–283. http://dx.doi.org/10.1111/eva.12196.
3. Martínez JL, Baquero F, Andersson DI. 2007. Predicting antibiotic resistance. Nat Rev Microbiol 5:958–965. http://dx.doi.org/10.1038/nrmicro1796.
4. Balasubramanian D, Schneper L, Kumari H, Mathee K. 2013. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res 41:1–20. http://dx.doi.org/10.1093/nar/gks1039.
5. Gooderham WJ, Hancock RE. 2009. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol Rev 33:279–294. http://dx.doi.org/10.1111/j.1574-6976.2008.00135.x.
6. Olivares J, Alvarez-Ortega C, Linares JF, Rojo F, Köhler T, Martínez JL. 2012. Overproduction of the multidrug efflux pump MexEF-OprN does not impair Pseudomonas aeruginosa fitness in competition tests, but produces specific changes in bacterial regulatory networks. Environ Microbiol 14:1968–1981. http://dx.doi.org/10.1111/j.1462-2920.2012.02727.x.
7. Gellatly SL, Hancock RE. 2013. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis 67:159–173. http://dx.doi.org/10.1111/2049-632X.12033.
8. Breidenstein EB, de la Fuente-Núñez C, Hancock RE. 2011. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 19:419–426. http://dx.doi.org/10.1016/j.tim.2011.04.005.
9. Juan C, Maciá MD, Gutiérrez O, Vidal C, Pérez JL, Oliver A. 2005. Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. Antimicrob Agents Chemother 49:4733–4738. http://dx.doi.org/10.1128/ AAC.49.11.4733-4738.2005.
10. Cabot G, Ocampo-Sosa AA, Tubau F, Macia MD, Rodríguez C, Moya B, Zamorano L, Suárez C, Peña C, Martínez-Martínez L, Oliver A, Spanish Network for Research in Infectious Diseases (REIPI). 2011. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob Agents Chemother 55: 1906–1911. http://dx.doi.org/10.1128/AAC.01645-10.
11. Normark S. 1995. Beta-lactamase induction in Gram-negative bacteria is intimately linked to peptidoglycan recycling. Microb Drug Resist 1:111–114. http://dx.doi.org/10.1089/mdr.1995.1.111.
12. Johnson JW, Fisher JF, Mobashery S. 2013. Bacterial cell-wall recycling. Ann N Y Acad Sci 1277:54–75. http://dx.doi.org/10.1111/j.1749-6632.2012.06813.x.
13. Zhang Y, Bao Q, Gagnon LA, Huletsky A, Oliver A, Jin S, Langaee T. 2010. ampG gene of Pseudomonas aeruginosa and its role in β -lactamase expression. Antimicrob Agents Chemother 54:4772–4779. http://dx.doi.org/10.1128/AAC.00009-10.
14. Asgarali A, Stubbs KA, Oliver A, Vocadlo DJ, Mark BL. 2009. Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal betalactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53:2274–2282. http://dx.doi.org/10.1128/AAC.01617-08.
15. Balcewich MD, Reeve TM, Orlikow EA, Donald LJ, Vocadlo DJ, Mark BL. 2010. Crystal structure of the AmpR effector binding domain provides insight into the molecular regulation of inducible AmpC beta-lactamase. J Mol Biol 400:998–1010. http://dx.doi.org/10.1016/j.jmb.2010.05.040.
16. Jacobs C, Huang LJ, Bartowsky E, Normark S, Park JT. 1994. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for betalactamase induction. EMBO J 13:4684–4694.
17. Lindberg F, Westman L, Normark S. 1985. Regulatory components in Citrobacter freundii ampC beta-lactamase induction. Proc Natl Acad Sci U S A 82:4620–4624. http://dx.doi.org/10.1073/pnas.82.14.4620.
18. Lee M, Zhang W, Hesek D, Noll BC, Boggess B, Mobashery S. 2009. Bacterial AmpD at the crossroads of peptidoglycan recycling and manifestation of antibiotic resistance. J Am Chem Soc 131:8742–8743. http://dx.doi.org/10.1021/ja9025566.
19. Lindberg F, Lindquist S, Normark S. 1987. Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii beta-lactamase. J Bacteriol 169:1923–1928.
20. Juan C, Moyá B, Pérez JL, Oliver A. 2006. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring highlevel beta-lactam resistance involves three AmpD homologues. Antimicrob Agents Chemother 50:1780–1787. http://dx.doi.org/10.1128/AAC.50.5.1780-1787.2006.
21. Moya B, Juan C, Albertí S, Pérez JL, Oliver A. 2008. Benefit of having multiple ampD genes for acquiring beta-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa. Antimicrob Agents Chemother 52:3694–3700. http://dx.doi.org/10.1128/AAC.00172-08.
22. Moya B, Dötsch A, Juan C, Blázquez J, Zamorano L, Haussler S, Oliver A. 2009. Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog 5:e1000353. http://dx.doi.org/10.1371/journal.ppat.1000353.
23. Ropy A, Cabot G, Sánchez-Diener I, Aguilera C, Moya B, Ayala JA, Oliver A. 2015. Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β -lactam resistance, and peptidoglycan structure. Antimicrob Agents Chemother 59:3925–3934. http://dx.doi.org/10.1128/AAC.05150-14.
24. Cavallari JF, Lamers RP, Scheurwater EM, Matos AL, Burrows LL. 2013. Changes to its peptidoglycan-remodeling enzyme repertoire modulate β -lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:3078–3084. http://dx.doi.org/10.1128/AAC.00268-13.
25. Lee M, Hesek D, Blázquez B, Lastochkin E, Boggess B, Fisher JF, Mobashery S. 2015. Catalytic spectrum of the penicillin-binding protein 4 of Pseudomonas aeruginosa, a nexus for the induction of β -lactam antibiotic resistance. J Am Chem Soc 137:190–200. http://dx.doi.org/10.1021/ja5111706.
26. Zamorano L, Moyà B, Juan C, Mulet X, Blázquez J, Oliver A. 2014. The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β -lactams, fitness, biofilm growth, and global regulation. Antimicrob Agents Chemother 58:5084–5095. http://dx.doi.org/10.1128/AAC.02556-14.
27. Balasubramanian D, Schneper L, Merighi M, Smith R, Narasimhan G, Lory S, Mathee K. 2012. The regulatory repertoire of Pseudomonas aeruginosa AmpC β -lactamase regulator AmpR includes virulence genes. PLoS One 7:e34067. http://dx.doi.org/10.1371/journal.pone.0034067.
28. Zamorano L, Moyá B, Juan C, Oliver A. 2010. Differential beta-lactam resistance response driven by ampD or dacB (PBP4) inactivation in genetically diverse Pseudomonas aeruginosa strains. J Antimicrob Chemother 65:1540–1542. http://dx.doi.org/10.1093/jac/dkq142.
29. Jander G, Rahme LG, Ausubel FM. 2000. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 182:3843–3845. http://dx.doi.org/10.1128/JB.182.13.3843-3845.2000.
30. Choi JY, Sifri CD, Goumnerov BC, Rahme LG, Ausubel FM, Calderwood SB. 2002. Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis. J Bacteriol 184:952–961. http://dx.doi.org/10.1128/jb.184.4.952-961.2002.
31. Mikkelsen H, McMullan R, Filloux A. 2011. The Pseudomonas aeruginosa reference strain PA14 displays increased virulence due to a mutation in ladS. PLoS One 6:e29113. http://dx.doi.org/10.1371/journal.pone.0029113.
32. Morosini MI, Ayala JA, Baquero F, Martínez JL, Blázquez J. 2000. Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Chemother 44:3137–3143. http://dx.doi.org/10.1128/AAC.44.11.3137-3143.2000.
33. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. 2008. The penicillinbinding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 32:234–258. http://dx.doi.org/10.1111/j.1574-6976.2008.00105.x. (Erratum, 32:556.)
34. Zamorano L, Reeve TM, Juan C, Moyá B, Cabot G, Vocadlo DJ, Mark BL, Oliver A. 2011. AmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains. Antimicrob Agents Chemother 55:1990–1996. http://dx.doi.org/10.1128/AAC.01688-10.
35. Folkesson A, Eriksson S, Andersson M, Park JT, Normark S. 2005. Components of the peptidoglycan-recycling pathway modulate invasion and intracellular survival of Salmonella enterica serovar Typhimurium. Cell Microbiol 7:147–155. http://dx.doi.org/10.1111/j.1462-5822.2004.00443.x.
36. Zhang W, Lee M, Hesek D, Lastochkin E, Boggess B, Mobashery S. 2013. Reactions of the three AmpD enzymes of Pseudomonas aeruginosa. J Am Chem Soc 135:4950–4953. http://dx.doi.org/10.1021/ja400970n.
37. Lee M, Artola-Recolons C, Carrasco-López C, Martínez-Caballero S, Hesek D, Spink E, Lastochkin E, Zhang W, Hellman LM, Boggess B, Hermoso JA, Mobashery S. 2013. Cell-wall remodeling by the zincprotease AmpDh3 from Pseudomonas aeruginosa. J Am Chem Soc 135: 12604–12607. http://dx.doi.org/10.1021/ja407445x.
38. Martínez-Caballero S, Lee M, Artola-Recolons C, Carrasco-López C, Hesek D, Spink E, Lastochkin E, Zhang W, Hellman LM, Boggess B, Mobashery S, Hermoso JA. 2013. Reaction products and the X-ray structure of AmpDh2, a virulence determinant of Pseudomonas aeruginosa. J Am Chem Soc 135:10318–10321. http://dx.doi.org/10.1021/ja405464b.
39. Burkinshaw BJ, Deng W, Lameignère E, Wasney GA, Zhu H, Worrall LJ, Finlay BB, Strynadka NC. 2015. Structural analysis of a specialized type III secretion system peptidoglycan-cleaving enzyme. J Biol Chem 290:10406–10417. http://dx.doi.org/10.1074/jbc.M115.639013.
40. Zahrl D, Wagner M, Bischof K, Bayer M, Zavecz B, Beranek A, Ruckenstuhl C, Zarfel GE, Koraimann G. 2005. Peptidoglycan degradation by specialized lytic transglycosylases associated with type III and type IV secretion systems. Microbiology 151:3455–3467. http://dx.doi.org/10.1099/mic.0.28141-0.
41. Roure S, Bonis M, Chaput C, Ecobichon C, Mattox A, Barrière C, Geldmacher N, Guadagnini S, Schmitt C, Prévost MC, Labigne A, Backert S, Ferrero RL, Boneca IG. 2012. Peptidoglycan maturation enzymes affect flagellar functionality in bacteria. Mol Microbiol 86:845–856. http://dx.doi.org/10.1111/mmi.12019. (Erratum, 88:456–457, 2013.)
42. Aschtgen MS, Thomas MS, Cascales E. 2010. Anchoring the type VI secretion system to the peptidoglycan: TssL, TagL, TagP… what else? Virulence 1:535–540. http://dx.doi.org/10.4161/viru.1.6.13732.
43. Koebnik R. 1995. Proposal for a peptidoglycan-associating alpha-helical motif in the C-terminal regions of some bacterial cell-surface proteins. Mol Microbiol 16:1269–1270. http://dx.doi.org/10.1111/j.1365-2958.1995.tb02348.x.
44. Bouveret E, Bénédetti H, Rigal A, Loret E, Lazdunski C. 1999. In vitro characterization of peptidoglycan-associated lipoprotein (PAL)-peptidoglycan and PAL-TolB interactions. J Bacteriol 181: 6306–6311.
45. Wehbi H, Portillo E, Harvey H, Shimkoff AE, Scheurwater EM, Howell PL, Burrows LL. 2011. The peptidoglycan-binding protein FimV promotes assembly of the Pseudomonas aeruginosa type IV pilus secretin. J Bacteriol 193:540–550. http://dx.doi.org/10.1128/JB.01048-10.
46. Mark BL, Vocadlo DJ, Oliver A. 2011. Providing β -lactams a helping hand: targeting the AmpC β-lactamase induction pathway. Future Microbiol 6:1415–1427. http://dx.doi.org/10.2217/fmb.11.128. (Erratum, 7:306, 2012.)
47. Lamers RP, Burrows LL. 2016. Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development. Future Med Chem 8:975–992. http://dx.doi.org/10.4155/fmc-2016-0017.
48. Jacoby GA. 2009. AmpC beta-lactamases. Clin Microbiol Rev 22:161–182. http://dx.doi.org/10.1128/CMR.00036-08.
49. Quénée L, Lamotte D, Polack B. 2005. Combined sacB-based negative selection and cre-lox antibiotic marker recycling for efficient gene deletion in Pseudomonas aeruginosa. BioTechniques 38:63–67. http://dx.doi.org/10.2144/05381ST01.
50. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249–264. http://dx.doi.org/10.1093/biostatistics/4.2.249.
51. Mulet X, Cabot G, Ocampo-Sosa AA, Domínguez MA, Zamorano L, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Oliver A, Spanish Network for Research in Infectious Diseases (REIPI). 2013. Biological markers of Pseudomonas aeruginosa epidemic high-risk clones. Antimicrob Agents Chemother 57:5527–5535. http://dx.doi.org/10.1128/AAC.01481-13.
52. Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E. 2003. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis. Infect Immun 71:2404–2413. http://dx.doi.org/10.1128/IAI.71.5.2404-2413.2003. 12704110.
53. Finney DJ. 1967. Probit analysis, 2nd ed. Cambridge University Press, Cambridge, United Kingdom